-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VhubXtXE9sNn4I013XBZCEsamVc7VwEL5QSRIpcBqp4KsvWg76/3cQ4atA7THDtv FpbhHrkKDeZUqPLL36SB/Q== 0001144204-07-052574.txt : 20071002 0001144204-07-052574.hdr.sgml : 20071002 20071002203143 ACCESSION NUMBER: 0001144204-07-052574 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20071002 FILED AS OF DATE: 20071002 DATE AS OF CHANGE: 20071002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULAWSKE-GUCK CATHERINE CENTRAL INDEX KEY: 0001388431 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33718 FILM NUMBER: 071151765 BUSINESS ADDRESS: BUSINESS PHONE: 954-835-1500 MAIL ADDRESS: STREET 1: 13794 NW 4TH STREET STREET 2: SUITE 213 CITY: SUNRISE STATE: FL ZIP: 33325 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOHEART, INC. CENTRAL INDEX KEY: 0001388319 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 650945967 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13794 NW 4TH STREET STREET 2: SUITE 212 CITY: SUNRISE STATE: FL ZIP: 33325 BUSINESS PHONE: 954-835-1500 MAIL ADDRESS: STREET 1: 13794 NW 4TH STREET STREET 2: SUITE 212 CITY: SUNRISE STATE: FL ZIP: 33325 3 1 v089327_ex.xml X0202 3 2007-10-02 0 0001388319 BIOHEART, INC. BHRT 0001388431 SULAWSKE-GUCK CATHERINE C/O BIOHEART, INC. 13794 NW 4TH STREET, SUITE 212 SUNRISE FL 33325 0 1 0 0 VP of Admin & HR Common Stock 24270 D Stock Option (right to buy) 5.67 2005-12-31 2015-12-31 Common Stock 309 D Stock Option (right to buy) 5.67 2014-01-11 Common Stock 15444 D Stock Option (right to buy) 8.47 2017-01-02 Common Stock 9267 D These options became exercisable as to 7,722 shares on January 11, 2007. The options will become exercisable as to the remaining 7,722 shares on January 11, 2008. These options will become exercisable in four equal installments on January 2, 2008, 2009, 2010 and 2011. Exhibit List Exhibit 24 - Confirming Statement /s/ Nicholas M. Burke, Attorney-In-Fact 2007-10-02 EX-24 2 ex24.txt EXHIBIT 24 CONFIRMING STATEMENT This Statement confirms that the undersigned has authorized and designated William H. Kline and/or Nicholas M. Burke to execute and file on the undersigned's behalf all Forms 3, 4 and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Bioheart, Inc. The authority of William H. Kline and/or Nicholas M. Burke under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4 and 5 with regard to his or her ownership of or transactions in securities of Bioheart, Inc., unless earlier revoked in writing. The undersigned acknowledges that neither William H. Kline nor Nicholas M. Burke is assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: 10/02/07 /s/ Catherine Sulawske-Guck -------- --------------------------- Name -----END PRIVACY-ENHANCED MESSAGE-----